nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—ACHE—Irinotecan—pancreatic cancer	0.225	0.396	CbGbCtD
Galantamine—BCHE—Irinotecan—pancreatic cancer	0.135	0.239	CbGbCtD
Galantamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0422	0.0743	CbGbCtD
Galantamine—CYP2D6—Erlotinib—pancreatic cancer	0.0358	0.0632	CbGbCtD
Galantamine—CYP3A4—Tamoxifen—pancreatic cancer	0.0268	0.0473	CbGbCtD
Galantamine—CYP3A4—Erlotinib—pancreatic cancer	0.0228	0.0402	CbGbCtD
Galantamine—CYP3A4—Irinotecan—pancreatic cancer	0.0206	0.0363	CbGbCtD
Galantamine—CYP2D6—Doxorubicin—pancreatic cancer	0.0177	0.0312	CbGbCtD
Galantamine—CYP3A4—Docetaxel—pancreatic cancer	0.0151	0.0266	CbGbCtD
Galantamine—CYP3A4—Sunitinib—pancreatic cancer	0.015	0.0265	CbGbCtD
Galantamine—CYP3A4—Doxorubicin—pancreatic cancer	0.0112	0.0198	CbGbCtD
Galantamine—Bronchitis—Epirubicin—pancreatic cancer	0.000399	0.000922	CcSEcCtD
Galantamine—Anaemia—Docetaxel—pancreatic cancer	0.000396	0.000915	CcSEcCtD
Galantamine—Gastritis—Doxorubicin—pancreatic cancer	0.000393	0.000908	CcSEcCtD
Galantamine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000392	0.000905	CcSEcCtD
Galantamine—Vomiting—Sunitinib—pancreatic cancer	0.00039	0.000902	CcSEcCtD
Galantamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000389	0.0009	CcSEcCtD
Galantamine—Rash—Sunitinib—pancreatic cancer	0.000387	0.000895	CcSEcCtD
Galantamine—Dermatitis—Sunitinib—pancreatic cancer	0.000387	0.000894	CcSEcCtD
Galantamine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000385	0.000891	CcSEcCtD
Galantamine—Headache—Sunitinib—pancreatic cancer	0.000385	0.000889	CcSEcCtD
Galantamine—Syncope—Docetaxel—pancreatic cancer	0.000384	0.000888	CcSEcCtD
Galantamine—Dysphagia—Doxorubicin—pancreatic cancer	0.000384	0.000887	CcSEcCtD
Galantamine—Pollakiuria—Epirubicin—pancreatic cancer	0.000383	0.000886	CcSEcCtD
Galantamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000383	0.000885	CcSEcCtD
Galantamine—Palpitations—Docetaxel—pancreatic cancer	0.000379	0.000875	CcSEcCtD
Galantamine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000377	0.00087	CcSEcCtD
Galantamine—Weight decreased—Epirubicin—pancreatic cancer	0.000375	0.000867	CcSEcCtD
Galantamine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000374	0.000865	CcSEcCtD
Galantamine—Cough—Docetaxel—pancreatic cancer	0.000374	0.000864	CcSEcCtD
Galantamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000373	0.000861	CcSEcCtD
Galantamine—Pneumonia—Epirubicin—pancreatic cancer	0.000372	0.00086	CcSEcCtD
Galantamine—Convulsion—Docetaxel—pancreatic cancer	0.000371	0.000858	CcSEcCtD
Galantamine—Hypertension—Docetaxel—pancreatic cancer	0.00037	0.000855	CcSEcCtD
Galantamine—Bronchitis—Doxorubicin—pancreatic cancer	0.000369	0.000853	CcSEcCtD
Galantamine—Arthralgia—Docetaxel—pancreatic cancer	0.000365	0.000843	CcSEcCtD
Galantamine—Chest pain—Docetaxel—pancreatic cancer	0.000365	0.000843	CcSEcCtD
Galantamine—Myalgia—Docetaxel—pancreatic cancer	0.000365	0.000843	CcSEcCtD
Galantamine—Nausea—Sunitinib—pancreatic cancer	0.000365	0.000843	CcSEcCtD
Galantamine—Renal failure—Epirubicin—pancreatic cancer	0.000363	0.00084	CcSEcCtD
Galantamine—Asthenia—Irinotecan—pancreatic cancer	0.000363	0.000839	CcSEcCtD
Galantamine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000362	0.000838	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000362	0.000837	CcSEcCtD
Galantamine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000359	0.000831	CcSEcCtD
Galantamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000357	0.000825	CcSEcCtD
Galantamine—Dry mouth—Docetaxel—pancreatic cancer	0.000357	0.000824	CcSEcCtD
Galantamine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000357	0.000824	CcSEcCtD
Galantamine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000354	0.000819	CcSEcCtD
Galantamine—Asthenia—Gemcitabine—pancreatic cancer	0.000353	0.000817	CcSEcCtD
Galantamine—Haematuria—Epirubicin—pancreatic cancer	0.000353	0.000815	CcSEcCtD
Galantamine—Confusional state—Docetaxel—pancreatic cancer	0.000353	0.000815	CcSEcCtD
Galantamine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00035	0.000808	CcSEcCtD
Galantamine—Epistaxis—Epirubicin—pancreatic cancer	0.000349	0.000806	CcSEcCtD
Galantamine—Weight decreased—Doxorubicin—pancreatic cancer	0.000347	0.000802	CcSEcCtD
Galantamine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000346	0.0008	CcSEcCtD
Galantamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000346	0.0008	CcSEcCtD
Galantamine—Pneumonia—Doxorubicin—pancreatic cancer	0.000344	0.000795	CcSEcCtD
Galantamine—Shock—Docetaxel—pancreatic cancer	0.000344	0.000795	CcSEcCtD
Galantamine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000343	0.000793	CcSEcCtD
Galantamine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000342	0.000791	CcSEcCtD
Galantamine—Tachycardia—Docetaxel—pancreatic cancer	0.000341	0.000789	CcSEcCtD
Galantamine—Skin disorder—Docetaxel—pancreatic cancer	0.00034	0.000785	CcSEcCtD
Galantamine—Bradycardia—Epirubicin—pancreatic cancer	0.000338	0.000781	CcSEcCtD
Galantamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000337	0.000779	CcSEcCtD
Galantamine—Renal failure—Doxorubicin—pancreatic cancer	0.000336	0.000777	CcSEcCtD
Galantamine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000335	0.000775	CcSEcCtD
Galantamine—Dizziness—Irinotecan—pancreatic cancer	0.000334	0.000773	CcSEcCtD
Galantamine—Haemoglobin—Epirubicin—pancreatic cancer	0.000334	0.000771	CcSEcCtD
Galantamine—Anorexia—Docetaxel—pancreatic cancer	0.000333	0.00077	CcSEcCtD
Galantamine—Rhinitis—Epirubicin—pancreatic cancer	0.000333	0.000769	CcSEcCtD
Galantamine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000333	0.000769	CcSEcCtD
Galantamine—Haemorrhage—Epirubicin—pancreatic cancer	0.000332	0.000767	CcSEcCtD
Galantamine—Hepatitis—Epirubicin—pancreatic cancer	0.000332	0.000767	CcSEcCtD
Galantamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000331	0.000766	CcSEcCtD
Galantamine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000328	0.000758	CcSEcCtD
Galantamine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000327	0.000756	CcSEcCtD
Galantamine—Hypotension—Docetaxel—pancreatic cancer	0.000327	0.000755	CcSEcCtD
Galantamine—Haematuria—Doxorubicin—pancreatic cancer	0.000326	0.000754	CcSEcCtD
Galantamine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000326	0.000754	CcSEcCtD
Galantamine—Urethral disorder—Epirubicin—pancreatic cancer	0.000325	0.000752	CcSEcCtD
Galantamine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000324	0.000748	CcSEcCtD
Galantamine—Epistaxis—Doxorubicin—pancreatic cancer	0.000323	0.000746	CcSEcCtD
Galantamine—Vomiting—Irinotecan—pancreatic cancer	0.000322	0.000743	CcSEcCtD
Galantamine—Dizziness—Fluorouracil—pancreatic cancer	0.00032	0.00074	CcSEcCtD
Galantamine—Visual impairment—Epirubicin—pancreatic cancer	0.00032	0.000739	CcSEcCtD
Galantamine—Rash—Irinotecan—pancreatic cancer	0.000319	0.000737	CcSEcCtD
Galantamine—Dermatitis—Irinotecan—pancreatic cancer	0.000319	0.000736	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000319	0.000736	CcSEcCtD
Galantamine—Headache—Irinotecan—pancreatic cancer	0.000317	0.000732	CcSEcCtD
Galantamine—Insomnia—Docetaxel—pancreatic cancer	0.000316	0.000731	CcSEcCtD
Galantamine—Paraesthesia—Docetaxel—pancreatic cancer	0.000314	0.000726	CcSEcCtD
Galantamine—Vomiting—Gemcitabine—pancreatic cancer	0.000313	0.000724	CcSEcCtD
Galantamine—Bradycardia—Doxorubicin—pancreatic cancer	0.000313	0.000723	CcSEcCtD
Galantamine—Somnolence—Docetaxel—pancreatic cancer	0.000311	0.000718	CcSEcCtD
Galantamine—Rash—Gemcitabine—pancreatic cancer	0.000311	0.000718	CcSEcCtD
Galantamine—Dermatitis—Gemcitabine—pancreatic cancer	0.00031	0.000717	CcSEcCtD
Galantamine—Eye disorder—Epirubicin—pancreatic cancer	0.00031	0.000717	CcSEcCtD
Galantamine—Tinnitus—Epirubicin—pancreatic cancer	0.000309	0.000715	CcSEcCtD
Galantamine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000309	0.000714	CcSEcCtD
Galantamine—Headache—Gemcitabine—pancreatic cancer	0.000309	0.000713	CcSEcCtD
Galantamine—Flushing—Epirubicin—pancreatic cancer	0.000308	0.000712	CcSEcCtD
Galantamine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000308	0.000712	CcSEcCtD
Galantamine—Vomiting—Fluorouracil—pancreatic cancer	0.000308	0.000712	CcSEcCtD
Galantamine—Rhinitis—Doxorubicin—pancreatic cancer	0.000308	0.000712	CcSEcCtD
Galantamine—Dyspepsia—Docetaxel—pancreatic cancer	0.000308	0.000711	CcSEcCtD
Galantamine—Hepatitis—Doxorubicin—pancreatic cancer	0.000307	0.00071	CcSEcCtD
Galantamine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000307	0.00071	CcSEcCtD
Galantamine—Rash—Fluorouracil—pancreatic cancer	0.000305	0.000706	CcSEcCtD
Galantamine—Dermatitis—Fluorouracil—pancreatic cancer	0.000305	0.000705	CcSEcCtD
Galantamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000304	0.000703	CcSEcCtD
Galantamine—Headache—Fluorouracil—pancreatic cancer	0.000303	0.000701	CcSEcCtD
Galantamine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000303	0.000701	CcSEcCtD
Galantamine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000303	0.000699	CcSEcCtD
Galantamine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000302	0.000698	CcSEcCtD
Galantamine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000302	0.000698	CcSEcCtD
Galantamine—Fatigue—Docetaxel—pancreatic cancer	0.000301	0.000697	CcSEcCtD
Galantamine—Angiopathy—Epirubicin—pancreatic cancer	0.000301	0.000696	CcSEcCtD
Galantamine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000301	0.000696	CcSEcCtD
Galantamine—Nausea—Irinotecan—pancreatic cancer	0.0003	0.000694	CcSEcCtD
Galantamine—Immune system disorder—Epirubicin—pancreatic cancer	0.0003	0.000693	CcSEcCtD
Galantamine—Constipation—Docetaxel—pancreatic cancer	0.000299	0.000691	CcSEcCtD
Galantamine—Arrhythmia—Epirubicin—pancreatic cancer	0.000297	0.000685	CcSEcCtD
Galantamine—Visual impairment—Doxorubicin—pancreatic cancer	0.000296	0.000684	CcSEcCtD
Galantamine—Nausea—Gemcitabine—pancreatic cancer	0.000293	0.000676	CcSEcCtD
Galantamine—Mental disorder—Epirubicin—pancreatic cancer	0.000291	0.000672	CcSEcCtD
Galantamine—Malnutrition—Epirubicin—pancreatic cancer	0.000289	0.000668	CcSEcCtD
Galantamine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000288	0.000666	CcSEcCtD
Galantamine—Nausea—Fluorouracil—pancreatic cancer	0.000288	0.000665	CcSEcCtD
Galantamine—Eye disorder—Doxorubicin—pancreatic cancer	0.000287	0.000663	CcSEcCtD
Galantamine—Tinnitus—Doxorubicin—pancreatic cancer	0.000286	0.000662	CcSEcCtD
Galantamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000286	0.000661	CcSEcCtD
Galantamine—Flushing—Doxorubicin—pancreatic cancer	0.000285	0.000659	CcSEcCtD
Galantamine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000285	0.000659	CcSEcCtD
Galantamine—Flatulence—Epirubicin—pancreatic cancer	0.000285	0.000658	CcSEcCtD
Galantamine—Tension—Epirubicin—pancreatic cancer	0.000284	0.000655	CcSEcCtD
Galantamine—Dysgeusia—Epirubicin—pancreatic cancer	0.000283	0.000654	CcSEcCtD
Galantamine—Nervousness—Epirubicin—pancreatic cancer	0.000281	0.000649	CcSEcCtD
Galantamine—Back pain—Epirubicin—pancreatic cancer	0.00028	0.000646	CcSEcCtD
Galantamine—Angiopathy—Doxorubicin—pancreatic cancer	0.000279	0.000644	CcSEcCtD
Galantamine—Muscle spasms—Epirubicin—pancreatic cancer	0.000278	0.000642	CcSEcCtD
Galantamine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000277	0.000641	CcSEcCtD
Galantamine—Body temperature increased—Docetaxel—pancreatic cancer	0.000276	0.000639	CcSEcCtD
Galantamine—Abdominal pain—Docetaxel—pancreatic cancer	0.000276	0.000639	CcSEcCtD
Galantamine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000274	0.000634	CcSEcCtD
Galantamine—Vision blurred—Epirubicin—pancreatic cancer	0.000272	0.000629	CcSEcCtD
Galantamine—Mental disorder—Doxorubicin—pancreatic cancer	0.000269	0.000622	CcSEcCtD
Galantamine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000268	0.00062	CcSEcCtD
Galantamine—Malnutrition—Doxorubicin—pancreatic cancer	0.000267	0.000618	CcSEcCtD
Galantamine—Anaemia—Epirubicin—pancreatic cancer	0.000267	0.000617	CcSEcCtD
Galantamine—Agitation—Epirubicin—pancreatic cancer	0.000266	0.000614	CcSEcCtD
Galantamine—Flatulence—Doxorubicin—pancreatic cancer	0.000263	0.000609	CcSEcCtD
Galantamine—Tension—Doxorubicin—pancreatic cancer	0.000262	0.000606	CcSEcCtD
Galantamine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000262	0.000605	CcSEcCtD
Galantamine—Malaise—Epirubicin—pancreatic cancer	0.000261	0.000602	CcSEcCtD
Galantamine—Nervousness—Doxorubicin—pancreatic cancer	0.00026	0.0006	CcSEcCtD
Galantamine—Vertigo—Epirubicin—pancreatic cancer	0.00026	0.0006	CcSEcCtD
Galantamine—Syncope—Epirubicin—pancreatic cancer	0.000259	0.000599	CcSEcCtD
Galantamine—Back pain—Doxorubicin—pancreatic cancer	0.000259	0.000598	CcSEcCtD
Galantamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000258	0.000595	CcSEcCtD
Galantamine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000257	0.000594	CcSEcCtD
Galantamine—Palpitations—Epirubicin—pancreatic cancer	0.000255	0.00059	CcSEcCtD
Galantamine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000254	0.000587	CcSEcCtD
Galantamine—Cough—Epirubicin—pancreatic cancer	0.000252	0.000583	CcSEcCtD
Galantamine—Vision blurred—Doxorubicin—pancreatic cancer	0.000252	0.000582	CcSEcCtD
Galantamine—Asthenia—Docetaxel—pancreatic cancer	0.000251	0.00058	CcSEcCtD
Galantamine—Convulsion—Epirubicin—pancreatic cancer	0.00025	0.000579	CcSEcCtD
Galantamine—Hypertension—Epirubicin—pancreatic cancer	0.000249	0.000577	CcSEcCtD
Galantamine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000248	0.000573	CcSEcCtD
Galantamine—Anaemia—Doxorubicin—pancreatic cancer	0.000247	0.000571	CcSEcCtD
Galantamine—Arthralgia—Epirubicin—pancreatic cancer	0.000246	0.000569	CcSEcCtD
Galantamine—Myalgia—Epirubicin—pancreatic cancer	0.000246	0.000569	CcSEcCtD
Galantamine—Chest pain—Epirubicin—pancreatic cancer	0.000246	0.000569	CcSEcCtD
Galantamine—Agitation—Doxorubicin—pancreatic cancer	0.000246	0.000568	CcSEcCtD
Galantamine—Anxiety—Epirubicin—pancreatic cancer	0.000245	0.000567	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000244	0.000565	CcSEcCtD
Galantamine—Discomfort—Epirubicin—pancreatic cancer	0.000243	0.000562	CcSEcCtD
Galantamine—Malaise—Doxorubicin—pancreatic cancer	0.000241	0.000557	CcSEcCtD
Galantamine—Dry mouth—Epirubicin—pancreatic cancer	0.000241	0.000556	CcSEcCtD
Galantamine—Vertigo—Doxorubicin—pancreatic cancer	0.00024	0.000555	CcSEcCtD
Galantamine—Syncope—Doxorubicin—pancreatic cancer	0.00024	0.000554	CcSEcCtD
Galantamine—Diarrhoea—Docetaxel—pancreatic cancer	0.000239	0.000553	CcSEcCtD
Galantamine—Confusional state—Epirubicin—pancreatic cancer	0.000238	0.00055	CcSEcCtD
Galantamine—Palpitations—Doxorubicin—pancreatic cancer	0.000236	0.000546	CcSEcCtD
Galantamine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000235	0.000543	CcSEcCtD
Galantamine—Cough—Doxorubicin—pancreatic cancer	0.000233	0.000539	CcSEcCtD
Galantamine—Shock—Epirubicin—pancreatic cancer	0.000232	0.000536	CcSEcCtD
Galantamine—Convulsion—Doxorubicin—pancreatic cancer	0.000232	0.000535	CcSEcCtD
Galantamine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000231	0.000535	CcSEcCtD
Galantamine—Dizziness—Docetaxel—pancreatic cancer	0.000231	0.000534	CcSEcCtD
Galantamine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000231	0.000534	CcSEcCtD
Galantamine—Hypertension—Doxorubicin—pancreatic cancer	0.000231	0.000534	CcSEcCtD
Galantamine—Tachycardia—Epirubicin—pancreatic cancer	0.00023	0.000532	CcSEcCtD
Galantamine—Skin disorder—Epirubicin—pancreatic cancer	0.000229	0.000529	CcSEcCtD
Galantamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000228	0.000527	CcSEcCtD
Galantamine—Chest pain—Doxorubicin—pancreatic cancer	0.000228	0.000526	CcSEcCtD
Galantamine—Arthralgia—Doxorubicin—pancreatic cancer	0.000228	0.000526	CcSEcCtD
Galantamine—Myalgia—Doxorubicin—pancreatic cancer	0.000228	0.000526	CcSEcCtD
Galantamine—Anxiety—Doxorubicin—pancreatic cancer	0.000227	0.000524	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000226	0.000523	CcSEcCtD
Galantamine—Discomfort—Doxorubicin—pancreatic cancer	0.000225	0.00052	CcSEcCtD
Galantamine—Anorexia—Epirubicin—pancreatic cancer	0.000225	0.00052	CcSEcCtD
Galantamine—Dry mouth—Doxorubicin—pancreatic cancer	0.000223	0.000515	CcSEcCtD
Galantamine—Vomiting—Docetaxel—pancreatic cancer	0.000222	0.000514	CcSEcCtD
Galantamine—Rash—Docetaxel—pancreatic cancer	0.00022	0.00051	CcSEcCtD
Galantamine—Hypotension—Epirubicin—pancreatic cancer	0.00022	0.000509	CcSEcCtD
Galantamine—Dermatitis—Docetaxel—pancreatic cancer	0.00022	0.000509	CcSEcCtD
Galantamine—Confusional state—Doxorubicin—pancreatic cancer	0.00022	0.000509	CcSEcCtD
Galantamine—Headache—Docetaxel—pancreatic cancer	0.000219	0.000506	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000215	0.000497	CcSEcCtD
Galantamine—Shock—Doxorubicin—pancreatic cancer	0.000215	0.000496	CcSEcCtD
Galantamine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000214	0.000495	CcSEcCtD
Galantamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000214	0.000494	CcSEcCtD
Galantamine—Insomnia—Epirubicin—pancreatic cancer	0.000213	0.000493	CcSEcCtD
Galantamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000213	0.000492	CcSEcCtD
Galantamine—Skin disorder—Doxorubicin—pancreatic cancer	0.000212	0.00049	CcSEcCtD
Galantamine—Paraesthesia—Epirubicin—pancreatic cancer	0.000212	0.000489	CcSEcCtD
Galantamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000211	0.000488	CcSEcCtD
Galantamine—Somnolence—Epirubicin—pancreatic cancer	0.00021	0.000485	CcSEcCtD
Galantamine—Anorexia—Doxorubicin—pancreatic cancer	0.000208	0.000481	CcSEcCtD
Galantamine—Nausea—Docetaxel—pancreatic cancer	0.000208	0.00048	CcSEcCtD
Galantamine—Dyspepsia—Epirubicin—pancreatic cancer	0.000208	0.00048	CcSEcCtD
Galantamine—Decreased appetite—Epirubicin—pancreatic cancer	0.000205	0.000474	CcSEcCtD
Galantamine—Hypotension—Doxorubicin—pancreatic cancer	0.000204	0.000471	CcSEcCtD
Galantamine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000204	0.000471	CcSEcCtD
Galantamine—Fatigue—Epirubicin—pancreatic cancer	0.000203	0.00047	CcSEcCtD
Galantamine—Constipation—Epirubicin—pancreatic cancer	0.000202	0.000466	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000199	0.00046	CcSEcCtD
Galantamine—Insomnia—Doxorubicin—pancreatic cancer	0.000197	0.000456	CcSEcCtD
Galantamine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000196	0.000453	CcSEcCtD
Galantamine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000194	0.000449	CcSEcCtD
Galantamine—Somnolence—Doxorubicin—pancreatic cancer	0.000194	0.000448	CcSEcCtD
Galantamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000193	0.000446	CcSEcCtD
Galantamine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000192	0.000444	CcSEcCtD
Galantamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.00019	0.000438	CcSEcCtD
Galantamine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000188	0.000435	CcSEcCtD
Galantamine—Fatigue—Doxorubicin—pancreatic cancer	0.000188	0.000435	CcSEcCtD
Galantamine—Constipation—Doxorubicin—pancreatic cancer	0.000187	0.000431	CcSEcCtD
Galantamine—Abdominal pain—Epirubicin—pancreatic cancer	0.000186	0.000431	CcSEcCtD
Galantamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000186	0.000431	CcSEcCtD
Galantamine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00018	0.000416	CcSEcCtD
Galantamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000178	0.000412	CcSEcCtD
Galantamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000174	0.000402	CcSEcCtD
Galantamine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000172	0.000399	CcSEcCtD
Galantamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000172	0.000399	CcSEcCtD
Galantamine—Asthenia—Epirubicin—pancreatic cancer	0.000169	0.000391	CcSEcCtD
Galantamine—Diarrhoea—Epirubicin—pancreatic cancer	0.000161	0.000373	CcSEcCtD
Galantamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000161	0.000372	CcSEcCtD
Galantamine—Asthenia—Doxorubicin—pancreatic cancer	0.000157	0.000362	CcSEcCtD
Galantamine—Dizziness—Epirubicin—pancreatic cancer	0.000156	0.00036	CcSEcCtD
Galantamine—Vomiting—Epirubicin—pancreatic cancer	0.00015	0.000347	CcSEcCtD
Galantamine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000149	0.000345	CcSEcCtD
Galantamine—Rash—Epirubicin—pancreatic cancer	0.000149	0.000344	CcSEcCtD
Galantamine—Dermatitis—Epirubicin—pancreatic cancer	0.000149	0.000343	CcSEcCtD
Galantamine—Headache—Epirubicin—pancreatic cancer	0.000148	0.000341	CcSEcCtD
Galantamine—Dizziness—Doxorubicin—pancreatic cancer	0.000144	0.000334	CcSEcCtD
Galantamine—Nausea—Epirubicin—pancreatic cancer	0.00014	0.000324	CcSEcCtD
Galantamine—Vomiting—Doxorubicin—pancreatic cancer	0.000139	0.000321	CcSEcCtD
Galantamine—Rash—Doxorubicin—pancreatic cancer	0.000138	0.000318	CcSEcCtD
Galantamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000137	0.000318	CcSEcCtD
Galantamine—Headache—Doxorubicin—pancreatic cancer	0.000137	0.000316	CcSEcCtD
Galantamine—Nausea—Doxorubicin—pancreatic cancer	0.00013	0.0003	CcSEcCtD
Galantamine—ACHE—Monoamine Transport—TSC2—pancreatic cancer	1.09e-06	0.00961	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—EZH2—pancreatic cancer	1.05e-06	0.00924	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—PIK3CB—pancreatic cancer	1.03e-06	0.00907	CbGpPWpGaD
Galantamine—CHRNE—ErbB2/ErbB3 signaling events—AKT1—pancreatic cancer	1.02e-06	0.00898	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—SST—pancreatic cancer	1.02e-06	0.00895	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	9.97e-07	0.00875	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HES1—pancreatic cancer	9.28e-07	0.00814	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—SST—pancreatic cancer	8.85e-07	0.00776	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—SRC—pancreatic cancer	8.28e-07	0.00727	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—HES1—pancreatic cancer	8.03e-07	0.00704	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—STAT3—pancreatic cancer	7.99e-07	0.00701	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	7.99e-07	0.00701	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—NRAS—pancreatic cancer	7.97e-07	0.00699	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	7.77e-07	0.00682	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TYMS—pancreatic cancer	7.62e-07	0.00669	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—GCG—pancreatic cancer	7.45e-07	0.00654	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HES1—pancreatic cancer	7.3e-07	0.00641	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—SST—pancreatic cancer	7.21e-07	0.00633	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—KRAS—pancreatic cancer	6.86e-07	0.00602	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—BCL2L1—pancreatic cancer	6.75e-07	0.00592	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—PLAU—pancreatic cancer	6.66e-07	0.00584	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—GCG—pancreatic cancer	6.65e-07	0.00584	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HES1—pancreatic cancer	6.34e-07	0.00556	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—PIK3CA—pancreatic cancer	6.3e-07	0.00553	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	6.12e-07	0.00537	CbGpPWpGaD
Galantamine—CHRNA9—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	5.84e-07	0.00512	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—HRAS—pancreatic cancer	5.83e-07	0.00512	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	5.63e-07	0.00494	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—RB1—pancreatic cancer	5.47e-07	0.0048	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—PPARG—pancreatic cancer	5.4e-07	0.00474	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	5.31e-07	0.00466	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—MMP2—pancreatic cancer	5.25e-07	0.00461	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HES1—pancreatic cancer	5.17e-07	0.00454	CbGpPWpGaD
Galantamine—CHRNA1—ErbB2/ErbB3 signaling events—AKT1—pancreatic cancer	5.15e-07	0.00452	CbGpPWpGaD
Galantamine—CHRNB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	5.1e-07	0.00448	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	5.05e-07	0.00443	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	5.04e-07	0.00443	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	4.98e-07	0.00437	CbGpPWpGaD
Galantamine—ACHE—Monoamine Transport—TNF—pancreatic cancer	4.95e-07	0.00435	CbGpPWpGaD
Galantamine—CHRNA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.84e-07	0.00425	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	4.83e-07	0.00424	CbGpPWpGaD
Galantamine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	4.75e-07	0.00417	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	4.65e-07	0.00408	CbGpPWpGaD
Galantamine—CHRNG—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.61e-07	0.00405	CbGpPWpGaD
Galantamine—CHRNA9—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.39e-07	0.00385	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—FUT8—pancreatic cancer	4.38e-07	0.00385	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CXCL8—pancreatic cancer	4.36e-07	0.00383	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	4.36e-07	0.00382	CbGpPWpGaD
Galantamine—CHRNE—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.34e-07	0.00381	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	4.33e-07	0.0038	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	4.28e-07	0.00376	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.1e-07	0.0036	CbGpPWpGaD
Galantamine—ACHE—ATF-2 transcription factor network—CCND1—pancreatic cancer	4.06e-07	0.00357	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	3.97e-07	0.00349	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—FUT8—pancreatic cancer	3.91e-07	0.00343	CbGpPWpGaD
Galantamine—CHRNB3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.84e-07	0.00337	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.8e-07	0.00334	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—PTEN—pancreatic cancer	3.7e-07	0.00325	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	3.67e-07	0.00322	CbGpPWpGaD
Galantamine—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.67e-07	0.00322	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.66e-07	0.00322	CbGpPWpGaD
Galantamine—CHRNA5—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.64e-07	0.00319	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.51e-07	0.00308	CbGpPWpGaD
Galantamine—CHRNG—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.47e-07	0.00304	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	3.45e-07	0.00302	CbGpPWpGaD
Galantamine—CHRNA9—Neuronal System—HRAS—pancreatic cancer	3.36e-07	0.00295	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	3.32e-07	0.00291	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.3e-07	0.0029	CbGpPWpGaD
Galantamine—CHRNE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.26e-07	0.00286	CbGpPWpGaD
Galantamine—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.23e-07	0.00283	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	3.22e-07	0.00283	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	3.21e-07	0.00282	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.18e-07	0.00279	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	3.15e-07	0.00277	CbGpPWpGaD
Galantamine—ACHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	3.01e-07	0.00264	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	3e-07	0.00264	CbGpPWpGaD
Galantamine—CHRNB3—Neuronal System—HRAS—pancreatic cancer	2.94e-07	0.00258	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	2.81e-07	0.00247	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.8e-07	0.00246	CbGpPWpGaD
Galantamine—CHRNA5—Neuronal System—HRAS—pancreatic cancer	2.79e-07	0.00245	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.76e-07	0.00243	CbGpPWpGaD
Galantamine—CHRNA6—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.76e-07	0.00242	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.69e-07	0.00236	CbGpPWpGaD
Galantamine—BCHE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	2.68e-07	0.00235	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PCSK1—pancreatic cancer	2.68e-07	0.00235	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CG—pancreatic cancer	2.68e-07	0.00235	CbGpPWpGaD
Galantamine—CHRNG—Neuronal System—HRAS—pancreatic cancer	2.66e-07	0.00233	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	2.64e-07	0.00232	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	2.59e-07	0.00227	CbGpPWpGaD
Galantamine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.57e-07	0.00225	CbGpPWpGaD
Galantamine—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.54e-07	0.00223	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—pancreatic cancer	2.53e-07	0.00222	CbGpPWpGaD
Galantamine—CHRNE—Neuronal System—HRAS—pancreatic cancer	2.5e-07	0.00219	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.45e-07	0.00215	CbGpPWpGaD
Galantamine—CHRNB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.43e-07	0.00213	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.4e-07	0.00211	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.39e-07	0.0021	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PCSK1—pancreatic cancer	2.39e-07	0.0021	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	2.38e-07	0.00209	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CD—pancreatic cancer	2.35e-07	0.00207	CbGpPWpGaD
Galantamine—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.32e-07	0.00204	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	2.3e-07	0.00202	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.29e-07	0.00201	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.28e-07	0.002	CbGpPWpGaD
Galantamine—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.21e-07	0.00194	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PPP2R5B—pancreatic cancer	2.19e-07	0.00192	CbGpPWpGaD
Galantamine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.18e-07	0.00192	CbGpPWpGaD
Galantamine—CHRNA6—Neuronal System—HRAS—pancreatic cancer	2.11e-07	0.00185	CbGpPWpGaD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.07e-07	0.00182	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CB—pancreatic cancer	2.05e-07	0.0018	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PTEN—pancreatic cancer	1.99e-07	0.00174	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—pancreatic cancer	1.96e-07	0.00172	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.93e-07	0.00169	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.91e-07	0.00168	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—HRAS—pancreatic cancer	1.86e-07	0.00163	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	1.8e-07	0.00158	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PTEN—pancreatic cancer	1.77e-07	0.00156	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.76e-07	0.00154	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.75e-07	0.00153	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PRSS1—pancreatic cancer	1.71e-07	0.0015	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.66e-07	0.00146	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.64e-07	0.00144	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.63e-07	0.00143	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.59e-07	0.00139	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.57e-07	0.00138	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.56e-07	0.00137	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.53e-07	0.00135	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PRSS1—pancreatic cancer	1.53e-07	0.00134	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ARG2—pancreatic cancer	1.48e-07	0.0013	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—HRAS—pancreatic cancer	1.48e-07	0.0013	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—HRAS—pancreatic cancer	1.46e-07	0.00128	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.42e-07	0.00125	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—GCG—pancreatic cancer	1.41e-07	0.00123	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	1.4e-07	0.00123	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.38e-07	0.00122	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.35e-07	0.00119	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—pancreatic cancer	1.34e-07	0.00117	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ARG2—pancreatic cancer	1.32e-07	0.00116	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMP—pancreatic cancer	1.3e-07	0.00114	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.27e-07	0.00112	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.27e-07	0.00112	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—pancreatic cancer	1.27e-07	0.00111	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—pancreatic cancer	1.26e-07	0.0011	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—GCG—pancreatic cancer	1.26e-07	0.0011	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—pancreatic cancer	1.25e-07	0.0011	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.25e-07	0.00109	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—pancreatic cancer	1.19e-07	0.00105	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.19e-07	0.00104	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.18e-07	0.00103	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMP—pancreatic cancer	1.16e-07	0.00102	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.08e-07	0.000949	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.07e-07	0.00094	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GLP1R—pancreatic cancer	1.05e-07	0.000918	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.05e-07	0.000918	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—pancreatic cancer	1.04e-07	0.000909	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DPYD—pancreatic cancer	1.03e-07	0.000903	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC2A2—pancreatic cancer	9.77e-08	0.000857	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.67e-08	0.000848	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	9.64e-08	0.000846	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.56e-08	0.000839	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GLP1R—pancreatic cancer	9.33e-08	0.000819	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.33e-08	0.000819	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DPYD—pancreatic cancer	9.18e-08	0.000806	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.83e-08	0.000775	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC2A2—pancreatic cancer	8.71e-08	0.000765	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.62e-08	0.000757	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	8.6e-08	0.000755	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.5e-08	0.000746	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.32e-08	0.00073	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.58e-08	0.000665	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CD44—pancreatic cancer	7.56e-08	0.000664	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.41e-08	0.00065	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	7.4e-08	0.00065	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—pancreatic cancer	7.39e-08	0.000648	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.34e-08	0.000644	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GCG—pancreatic cancer	7.25e-08	0.000637	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	7.03e-08	0.000617	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STK11—pancreatic cancer	6.82e-08	0.000598	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CD44—pancreatic cancer	6.75e-08	0.000592	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.61e-08	0.00058	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	6.6e-08	0.00058	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—pancreatic cancer	6.59e-08	0.000578	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.55e-08	0.000575	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GCG—pancreatic cancer	6.47e-08	0.000568	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.4e-08	0.000562	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	6.15e-08	0.00054	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ARG2—pancreatic cancer	6.09e-08	0.000535	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STK11—pancreatic cancer	6.08e-08	0.000534	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TYMS—pancreatic cancer	5.87e-08	0.000515	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.71e-08	0.000501	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	5.67e-08	0.000498	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	5.49e-08	0.000482	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMP—pancreatic cancer	5.32e-08	0.000467	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TYMS—pancreatic cancer	5.23e-08	0.000459	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	5.06e-08	0.000444	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—pancreatic cancer	4.77e-08	0.000419	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.59e-08	0.000403	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.52e-08	0.000396	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—pancreatic cancer	4.3e-08	0.000378	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	4.29e-08	0.000377	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—pancreatic cancer	4.26e-08	0.000373	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DPYD—pancreatic cancer	4.22e-08	0.000371	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—pancreatic cancer	4.15e-08	0.000365	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.03e-08	0.000354	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.01e-08	0.000352	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ARG2—pancreatic cancer	3.98e-08	0.00035	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—pancreatic cancer	3.84e-08	0.000337	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—pancreatic cancer	3.78e-08	0.000332	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—pancreatic cancer	3.71e-08	0.000325	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.48e-08	0.000306	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—pancreatic cancer	3.38e-08	0.000296	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—pancreatic cancer	3.3e-08	0.00029	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—pancreatic cancer	3.27e-08	0.000287	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CD44—pancreatic cancer	3.1e-08	0.000272	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GCG—pancreatic cancer	2.97e-08	0.000261	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—pancreatic cancer	2.94e-08	0.000258	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—pancreatic cancer	2.92e-08	0.000256	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—pancreatic cancer	2.85e-08	0.00025	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.81e-08	0.000246	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STK11—pancreatic cancer	2.8e-08	0.000245	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.76e-08	0.000242	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.62e-08	0.00023	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—pancreatic cancer	2.54e-08	0.000223	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.41e-08	0.000211	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CD44—pancreatic cancer	2.03e-08	0.000178	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—pancreatic cancer	2.01e-08	0.000176	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—pancreatic cancer	1.96e-08	0.000172	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.94e-08	0.000171	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.83e-08	0.00016	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.79e-08	0.000157	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.77e-08	0.000155	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.7e-08	0.00015	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—pancreatic cancer	1.64e-08	0.000144	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.57e-08	0.000138	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.55e-08	0.000136	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—pancreatic cancer	1.47e-08	0.000129	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.35e-08	0.000119	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.34e-08	0.000118	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—pancreatic cancer	1.28e-08	0.000112	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.17e-08	0.000103	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.15e-08	0.000101	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.11e-08	9.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.01e-08	8.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	8.85e-09	7.76e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	8.77e-09	7.69e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	8.25e-09	7.24e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—pancreatic cancer	7.64e-09	6.71e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	6.74e-09	5.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.39e-09	4.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.41e-09	3.87e-05	CbGpPWpGaD
